Age at menopause of HIV-infected women: A review

Gynecological Endocrinology

Volumn 24, Issue 2, 2008, Pages 84-86

  Conde, Délio Marques ^a,c   Pinto Neto, Aarão Mendes ^b   Costa Paiva, Lúcia ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c NONE   (Brazil)

Author keywords

Age; Antiretroviral therapy; HIV; Menopause; Ovarian function

Indexed keywords

ANTIRETROVIRUS AGENT; FOLLITROPIN; METHADONE;

BONE DENSITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENOPAUSAL SYNDROME; MENOPAUSE; MORTALITY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SURVIVAL;

AGE OF ONSET; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; MENOPAUSE; MENOPAUSE, PREMATURE;

EID: 38349145915     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701806870     Document Type: Review

References (23)

1. Joint United Nations Programme on HIV/AIDS. 2006 AIDS epidemic update [Internet], Geneva: UNAIDS; 2006 Dec [cited 2007 Aug 2]. Available from: http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_en.pdf
2. Brazilian Health Ministry. AIDS/STD epidemiologic bulletin 2005 [Internet], Brasilia, (DF): Brazilian Health Ministry; [cited 2007 Aug 2]. Available from: http://www.aids.gov.br/data/documents/storedDocuments/ %7BB8EFSDAF-23AE-4891-AD36-1903553A3174%7D/%7BED005A42-14BE-4f7E-98A7- E6AD7CD9A76D%7DBOLETIM.PDF
3. Hacker MA, Petersen ML, Enriquez M, Bastos FI. Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality. Rev Panam Salud Publica 2004;16:78-83.
4. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE. HIV infection and bone mineral density in middle-aged women. Clin Infect Dis 2006;42:1014-1020.
5. Clark RA, Cohn SE, Jarek C, Craven KS, Lyons C, Jacobson M, Kamemoto L. Perimenopausal symptomatology among HIV-infected women at least 40 years of age. J Acquir Immune Defic Syndr 2000;23:99-100.
6. Fantry LE, Zhan M, Taylor GH, Sill AM, Flaws JA. Age of menopause and menopausal symptoms in HIV-infected women. AIDS Patient Care STDS 2005;19:703-711.
7. Miller SA, Santoro N, Lo Y, Howard AA, Arnsten JH, Floris-Moore M, Moskaleva G, Schoenbaum EE. Menopause symptoms in HIV-infected and drug-using women. Menopause 2005;12:348-356.
8. Ferreira CE, Pinto-Neto AM, Conde DM, Costa-Paiva L, Morais SS, Magalhaes J. Age at menopause and factors associated with menopause symptoms in HIV-infected women. Menopause 2006;13:1021.
9. Ferreira CE, Pinto-Neto AM, Conde DM, Costa-Paiva L, Morais SS, Magalhaes J. Menopause symptoms in women infected with HIV: prevalence and associated factors. Gynecol Endocrinol 2007;23:198-205.
10. Cejtin HE, Kalinowski A, Bacchetti P, Taylor RN, Watts DH, Kim S, Massad LS, Preston-Martin S, Anastos K, Moxley M, et al. Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction. Obstet Gynecol 2006;108:1423-1431.
11. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001. Menopause 2001;8:402-407.
12. Smith SM, Mefford M, Sodora D, Klase Z, Singh M, Alexander N, Hess D, Marx PA. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 2004;18:1637-1643.
13. Katagiri D, Hayashi H, Victoriano AF, Okamoto T, Onozaki K. Estrogen stimulates transcription of human immunodeficiency virus type 1 (HIV-1). Int Immunopharmacol 2006;6:170-181.
14. Gold EB, Bromberger J, Crawford S, Samuels S, Greendale GA, Harlow SD, Skurnick J. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001;153:865-874.
15. Parazzini F; Progetto Menopause Italia Study Group. Determinants of age at menopause in women attending menopause clinics in Italy. Maturitas 2007;56:280-287.
16. Castelo-Branco C, Blumel JE, Chedraui P, Calle A, Bocanera R, Depiano E, Figueroa-Casas P, Gonzalez C, Martino M, Royer M, et al. Age at menopause in Latin America. Menopause 2006;13:706-712.
17. Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 1998;83:1875-1880.
18. Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005;162:1089-1097.
19. DAD Study Group, Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiebaut R, De Wit S, Kirk O, Fontas E, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356:1723-1735.
20. Schoenbaum EE, Hartel D, Lo Y, Howard AA, Floris-Moore M, Arnsten JH, Santoro N. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis 2005;41:1517-1524.
21. Cejtin HE, Kim S, Taylor RN, Watts DH, Minkoff HL, Massad LS, Preston-Martin S, Anastos K. Menopause in the women's Interagency HIV Study (WIHS) [Abstract WePeD6504]. Presented at XV International AIDS Conference; 2004 Jul 11-16; Bangkok.
22. Santoro N, Arnsten JH, Buono D, Howard AA, Schoenbaum EE. Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women. J Womens Health (Larchmt) 2005;14:898-905.
23. Vehid S, Aran SN, Koksal S, Isiloglu H, Senocak M. The prevalence and the age at the onset of menopause in Turkish women in rural area. Saudi Med J 2006;27:1381-1386.